Pharma & Biotech

Harmony Biosciences Holdings has delivered a stunning market surprise, propelling its equity value to remarkable heights. The biopharmaceutical firm's preliminary...

Soleno Therapeutics shares are approaching a pivotal moment with the upcoming quarterly results announcement scheduled for November 4. Following a...

Investors are closely watching Opko Health (OPK) as the company prepares to release its third-quarter 2025 financial results after market...

The fate of Anavex now rests with European drug regulators, creating a high-stakes scenario for investors. While the biotechnology firm...

The biotech sector has been challenging for many companies, but Ocugen stands out with a remarkable trading session. On Friday,...

The biotechnology software firm Simulations Plus finds itself navigating turbulent waters as legal pressures collide with a mixed financial performance....

Novo Nordisk finds itself navigating turbulent waters as a sweeping leadership overhaul creates uncertainty for shareholders. The Danish pharmaceutical giant's...

The landscape of mRNA biotechnology is poised for a significant transformation as BioNTech has officially commenced its takeover bid for...

Cellectar Biosciences finds itself at a pivotal moment, with a convergence of regulatory progress, financial maneuvers, and pipeline expansion creating...

The biotechnology sector is experiencing a powerful resurgence, with Danaher Corporation emerging as a key beneficiary. The life sciences conglomerate...